Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Pharmaceutical drug production value Japan 2016, by prefecture

Pharmaceutical drug production value in Japan in 2016, by prefecture (in billion Japanese yen)

by Statista Research Department, last edited Oct 19, 2018
Pharmaceutical drug production value Japan 2016, by prefecture The statistic depicts the pharmaceutical drug production value in Japan in 2016, broken down by prefecture. That year, the amount of drug production in Toyama prefecture accounted for the largest share with approximately 622 billion Japanese yen. In Tottori prefecture, the drug production value reached about 11 million yen.
Show more

Pharmaceutical drug production value in Japan in 2016, by prefecture (in billion Japanese yen)

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Top pharmaceutical drugs"
  • Global overview
  • Select therapy classes - global
  • U.S. overview
  • Select therapy classes - U.S.
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.